top of page
Our Co-Founder Prof. Frauke Alves
"I see great potential in the technology developed by NanoDrug Delivery GmbH. Their approach to targeted drug delivery could significantly improve treatment options for oncology patients."

Prof. Dr. xxxxx xxxxxxxx

Head of Oncology
University Medical Center Göttingen

bottom of page